Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03710239 · ClinicalTrials.gov registry record · NA
OPIOID Study - Pain With Osmotic Dilators
A NA study of Abortion in Second Trimester, sponsored by Albany Medical College.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT03710239: Completed NA study of Abortion in Second Trimester, sponsored by Albany Medical College.
NCT03710239 is a NA study of Abortion in Second Trimester that has completed, run by Albany Medical College. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03710239, a NA study of Abortion in Second Trimester, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparison of pain levels and pain medications utilized following insertion of two different types of osmotic dilators.
Primary Outcome
Timed surveys measuring pain on Numeric Rating Scale (0-10), administered approximately 24 hours after dilator placement
Conditions Studied
Interventions
- DEVICE Dilapan-S
- DEVICE Laminaria
Study Locations (1)
New York
- Albany Medical Center Obstetrics and Gynecology - Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2018-10-02 |
| Est. Completion | 2020-03-11 |
| Phase | NA |
What the finished NCT03710239 record still lists
NCT03710239 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Abortion in Second Trimester appearing as the primary indexed condition, and to 2 interventions - of which Dilapan-S is the first listed.
NCT03710239 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03710239 about?
NCT03710239 is a clinical study titled "OPIOID Study - Pain With Osmotic Dilators". Comparison of pain levels and pain medications utilized following insertion of two different types of osmotic dilators.
What is the current status of trial NCT03710239?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2018-10-02. Estimated completion is 2020-03-11.
What conditions does trial NCT03710239 study?
This clinical trial studies the following conditions: Abortion in Second Trimester.
What interventions are being tested in trial NCT03710239?
The interventions under investigation include: Dilapan-S (DEVICE), Laminaria (DEVICE).
Who is sponsoring clinical trial NCT03710239?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03710239 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03710239's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI